AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpoint
Authors: Wise, R Andrews, JM Ashby, JP
Citation: R. Wise et al., Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpoint, J ANTIMICRO, 48(4), 2001, pp. 563-567
Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae
Authors: Boswell, FJ Andrews, JM Wise, R
Citation: Fj. Boswell et al., Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae, J ANTIMICRO, 48(3), 2001, pp. 446-447
In vitro susceptibility testing of BMS-284756 by the BSAC standardized disc testing method
Authors: Andrews, JM Wise, R
Citation: Jm. Andrews et R. Wise, In vitro susceptibility testing of BMS-284756 by the BSAC standardized disc testing method, J ANTIMICRO, 48(2), 2001, pp. 322-324
Determination of minimum inhibitory concentrations
Authors: Andrews, JM
Citation: Jm. Andrews, Determination of minimum inhibitory concentrations, J ANTIMICRO, 48, 2001, pp. 5-16
The development of the BSAC standardized method of disc diffusion testing
Authors: Andrews, JM
Citation: Jm. Andrews, The development of the BSAC standardized method of disc diffusion testing, J ANTIMICRO, 48, 2001, pp. 29-42
BSAC standardized disc susceptibility testing method
Authors: Andrews, JM
Citation: Jm. Andrews, BSAC standardized disc susceptibility testing method, J ANTIMICRO, 48, 2001, pp. 43-57
Lung concentrations of telithromycin after oral dosing
Authors: Khair, OA Andrews, JM Honeybourne, D Jevons, G Vacheron, F Wise, R
Citation: Oa. Khair et al., Lung concentrations of telithromycin after oral dosing, J ANTIMICRO, 47(6), 2001, pp. 837-840
Pharmacokinetics and tissue penetration of gemifloxacin following a singleoral dose
Authors: Gee, T Andrews, JM Ashby, JP Marshall, G Wise, R
Citation: T. Gee et al., Pharmacokinetics and tissue penetration of gemifloxacin following a singleoral dose, J ANTIMICRO, 47(4), 2001, pp. 431-434
Nutrient-induced spatial patterning of human duodenal motor function
Authors: Andrews, JM Doran, SM Hebbard, GS Malbert, CH Horowitz, M Dent, J
Citation: Jm. Andrews et al., Nutrient-induced spatial patterning of human duodenal motor function, AM J P-GAST, 280(3), 2001, pp. G501-G509
Interpreting electrolyte, anion gap, and total carbon dioxide data
Authors: Andrews, JM Grindem, CB
Citation: Jm. Andrews et Cb. Grindem, Interpreting electrolyte, anion gap, and total carbon dioxide data, VET MED-US, 95(7), 2000, pp. 548-553
The in vitro activity of ABT773, a new ketolide antimicrobial agent
Authors: Andrews, JM Weller, TMA Ashby, JP Walker, RM Wise, R
Citation: Jm. Andrews et al., The in vitro activity of ABT773, a new ketolide antimicrobial agent, J ANTIMICRO, 46(6), 2000, pp. 1017-1022
Effect of medium composition on the MIC breakpoint for gentamicin
Authors: Andrews, JM
Citation: Jm. Andrews, Effect of medium composition on the MIC breakpoint for gentamicin, J ANTIMICRO, 46(5), 2000, pp. 851-852
Evaluation of the Oxoid Aura image system for measuring zones of inhibition with the disc diffusion technique
Authors: Andrews, JM Boswell, FJ Wise, R
Citation: Jm. Andrews et al., Evaluation of the Oxoid Aura image system for measuring zones of inhibition with the disc diffusion technique, J ANTIMICRO, 46(4), 2000, pp. 535-540
In vitro susceptibility of Neisseria meningitidis - J Antimicrob Chemother2000; 45 : 548-549
Authors: Andrews, JM Wise, R
Citation: Jm. Andrews et R. Wise, In vitro susceptibility of Neisseria meningitidis - J Antimicrob Chemother2000; 45 : 548-549, J ANTIMICRO, 45(4), 2000, pp. 548-549
Comparison of the Etest with a conventional agar dilution method in evaluating the in vitro activity of moxifloxacin
Authors: Andrews, JM Wise, R
Citation: Jm. Andrews et R. Wise, Comparison of the Etest with a conventional agar dilution method in evaluating the in vitro activity of moxifloxacin, J ANTIMICRO, 45(2), 2000, pp. 257-258
Establishing MIC breakpoints for coagulase-negative staphylococci to oxacillin
Authors: Andrews, JM Boswell, FJ Wise, R
Citation: Jm. Andrews et al., Establishing MIC breakpoints for coagulase-negative staphylococci to oxacillin, J ANTIMICRO, 45(2), 2000, pp. 259-261
Repression of tax-mediated human T-lymphotropic virus type 1 transcriptionby inducible cAMP early repressor (ICER) protein in peripheral blood mononuclear cells
Authors: Newbound, GC O'Rourke, JP Collins, ND Andrews, JM DeWille, J Lairmore, MD
Citation: Gc. Newbound et al., Repression of tax-mediated human T-lymphotropic virus type 1 transcriptionby inducible cAMP early repressor (ICER) protein in peripheral blood mononuclear cells, J MED VIROL, 62(2), 2000, pp. 286-292
Medieval Cyprus. Studies in art, architecture, and history in memory of Doula Mouriki
Authors: Andrews, JM
Citation: Jm. Andrews, Medieval Cyprus. Studies in art, architecture, and history in memory of Doula Mouriki, COMITATUS, 31, 2000, pp. 276-278
Tentative minimum inhibitory concentration and zone diameter breakpoints for moxifloxacin using BSAC criteria
Authors: Andrews, JM Ashby, JP Jevons, GM Wise, R
Citation: Jm. Andrews et al., Tentative minimum inhibitory concentration and zone diameter breakpoints for moxifloxacin using BSAC criteria, J ANTIMICRO, 44(6), 1999, pp. 819-822
The in-vitro activity and tentative breakpoint of gemifloxacin, a new fluoroquinolone
Authors: Wise, R Andrews, JM
Citation: R. Wise et Jm. Andrews, The in-vitro activity and tentative breakpoint of gemifloxacin, a new fluoroquinolone, J ANTIMICRO, 44(5), 1999, pp. 679-688
A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose
Authors: Wise, R Andrews, JM Ashby, JP Marshall, J
Citation: R. Wise et al., A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose, J ANTIMICRO, 44(5), 1999, pp. 701-704
Bactericidal properties of moxifloxacin and post-antibiotic effect
Authors: Boswell, FJ Andrews, JM Wise, R Dalhoff, A
Citation: Fj. Boswell et al., Bactericidal properties of moxifloxacin and post-antibiotic effect, J ANTIMICRO, 43, 1999, pp. 43-49
Study to assess the reliability of a disc diffusion method for determiningthe sensitivity of Gram-positive pathogens to dalfopristin/quinupristin
Authors: Andrews, JM Ashby, JP Wise, R
Citation: Jm. Andrews et al., Study to assess the reliability of a disc diffusion method for determiningthe sensitivity of Gram-positive pathogens to dalfopristin/quinupristin, J ANTIMICRO, 43(1), 1999, pp. 141-143
The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopy
Authors: Honeybourne, D Andrews, JM Cunningham, B Jevons, G Wise, R
Citation: D. Honeybourne et al., The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopy, J ANTIMICRO, 43(1), 1999, pp. 153-155
Validation of a novel luminal flow velocimeter with video fluoroscopy and manometry in the human esophagus
Authors: Andrews, JM Nathan, H Malbert, CH Verhagen, MAMT Gabb, M Hebbard, GS Kilpatrick, D MacDonald, S Rayner, CK Doran, S Omari, T O'Young, E Frisby, C Fraser, RJ Schoeman, M Horowitz, M Dent, J
Citation: Jm. Andrews et al., Validation of a novel luminal flow velocimeter with video fluoroscopy and manometry in the human esophagus, AM J P-GAST, 39(4), 1999, pp. G886-G894
Risultati: 1-25 | 26-33